Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
Quest Diagnostics reported flat revenue growth but robust profits for the second quarter of…
From - Laboratory Industry Report
Exact Sciences' molecular colorectal cancer test will be included in the National Committee for Quality Assurance's (NCQA) updated guidelines for screening for…
From - Laboratory Industry Report
Trovagene has entered into a pact with the University of Michigan Comprehensive Cancer Center in order to develop a molecular test for the earlier detection and…